Sign In  |  Register  |  About San Rafael  |  Contact Us

San Rafael, CA
September 01, 2020 1:37pm
7-Day Forecast | Traffic

  • Search Hotels in San Rafael

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Age/Related Macular Degeneration

Recent news which mentions Age/Related Macular Degeneration

Opthea Shares OPT-302 data In Patients With Subtype Of Age-Related Macular Degeneration
Tickers OPT
Tags News Biotech General
From Benzinga
Viteyes Focuses on Eye Health Nutrition during Age-Related Macular Degeneration (AMD) Awareness Month
Tickers AMD
Tags Health Farmington Hills AMD Month
From PRLog
FDA Approves First Injectable Eye Medicine For Vision Loss Disorder - Genentech's Vabysmo
Tickers RHHBF RHHBY RHHVF
Tags Briefs RHHBF General
From Benzinga
Adverum Outlines Development Plan For ADVM-022 Gene Therapy In Wet AMD
Tickers ADVM
Tags Biotech Benzinga gene therapy
From Benzinga
Lineage, Genentech Ink Cell Therapy Licensing Pact For Ocular Diseases
Tickers LCTX RHHBF RHHBY RHHVF
Tags why it's moving Small Cap RHHBY
From Benzinga
Eyecheck Sets Scientific Standard for Premium Ocular Health Supplements
Tickers AMD
Tags age/related macular degeneration AMD Vitamins
From PRUnderground
Why Are EyePoint Shares Trading Higher Today?
Tickers EYPT
Tags Briefs Movers News
From Benzinga
Why Did Mizuho Upgrade This Biotech Stock Focused On Age-Related Eye Diseases?
Tickers UBX
Tags Diabetic Macular Edema UBX Biotech
From Benzinga
4D Molecular To Test Its Wet AMD Gene Therapy In Patients
Tickers FDMT
Tags Briefs News Movers
From Benzinga
Unity Biotechnology Stock Falls After Updated Data From Wet AMD Candidate
Tickers UBX
Tags Movers News General
From Benzinga
Graybug Vision Posts Six-Month Extension GB-102 Data Of Wet AMD Trial
Tickers GRAY REGN
Tags REGN GRAY Biotech
From Benzinga
AbbVie, RegenXBio Ink $1.75B Retinal Gene Therapy Collaboration
Tickers ABBV RGNX
Tags Trading Ideas Biotech Market News
From Benzinga
Regeneron Touts Mid-Stage Win For Higher Dose Of Eylea In Age-related Macular Degeneration
Tickers BAYRY BAYZF REGN
Tags Health Care BAYZF Phase 2 Trial
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SanRafael.com & California Media Partners, LLC. All rights reserved.